The medications covered under the Bridge program All four medications included in the program are in the GLP-1 family, which means they work by mimicking gut hormones to lower appetite, slow digestion, and regulate blood sugar, but theyre not identical
By the 2010s, athletes adopted it for its tissue-repairing effects, supported by preclinical data
Many manufacturers use cutting-edge delivery techniques like liposomal encapsulationwhich shields the glutathione molecule and improves its absorptionto solve this
Safety concerns arise with overthecounter peptide purchases: lack of FDA approval, purity, and potential immunogenicity
GLP-1 Drugs and Addiction GLP-1 receptor agonists were originally developed to help manage type 2 diabetes, but their popularity has surged in recent years because of their effectiveness for weight loss